v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue $ 0 $ 8
Operating expenses:    
Research and development 43 9,154
General and administrative 3,489 6,631
Restructuring and other charges 476 25,173
Total operating expenses 4,008 40,958
Loss from operations (4,008) (40,950)
Other income (expense):    
Interest and investment income 695 1,425
Change in fair value of purchase warrant liability 2,308 16,173
Other expense (0) (2)
Total other income (expense), net 3,003 17,596
Loss before income taxes (1,005) (23,354)
Income tax expense 0 (5)
Net loss $ (1,005) $ (23,359)
Net loss per share - basic and diluted $ (0.08) $ (1.92)
Net loss per share - basic and diluted $ (0.08) $ (1.92)
Weighted-average common stock outstanding - basic and diluted 12,311,909 12,196,209
Weighted-average common stock outstanding - basic and diluted 12,311,909 12,196,209
Comprehensive income (loss):    
Net Income (Loss) $ (1,005) $ (23,359)
Net unrealized (loss) gain on marketable securities 0 (6)
Comprehensive loss $ (1,005) $ (23,365)